MTOR and urinary bladder cancer: Therefore, to simulate the downstream effects of loss of function mutations in MLL2 and to investigate their relationships with alterations of the mTOR pathway, we carried out MLL2 silencing with a specific short hairpin RNA in T24 human bladder cancer cells where the MTOR gene is not altered (Figure 3C, left panel).